Skip to main content
Top
Published in: European Journal of Pediatrics 6/2020

01-06-2020 | Aneurysm | Original Article

Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study

Authors: Lei Liu, Chunyan Luo, Yimin Hua, Mei Wu, Shuran Shao, Xiaoliang Liu, Kaiyu Zhou, Chuan Wang

Published in: European Journal of Pediatrics | Issue 6/2020

Login to get access

Abstract

To identify the risk factors of progression and persistence of small- and medium-sized coronary artery aneurysm (CAA) in a contemporary cohort of patients with Kawasaki disease (KD) and to determine the relationship between CAA progression and persistence. A total of 89 KD patients with small- and medium-sized CAA were prospectively enrolled. All patients were followed up at least for 2 years by serial echocardiography. Multivariate logistic regression analysis was conducted to evaluate independent risk factors for CAA progression and persistence. A total of 46 (51.7%) and 73 (82.0%) patients showed echocardiographic CAA regression by 1 month and 24 months of follow-up, respectively. CAA progression was documented in 12 (13.5%) patients during follow-up. The initial aneurysm size according to CAA classification (OR 0.089, 95% CI 0.013–0.634, P = 0.016) and CAA progression (OR 42.618, 95% CI 3.740–485.6, P = 0.003) were independently associated with CAA persistence. The number of involved coronary arteries (OR 0.223, 95% CI 0.065–0.767, P = 0.015) and lymphocyte proportion (OR 1.327, 95% CI 1.019–1.727, P = 0.040) were independently associated with CAA progression.
Conclusion: Patients with KD and greater initial aneurysm size, CAA progression, more involved coronary arteries, and lower lymphocyte proportion may require intensive cardiac monitoring and adjuvant therapies.
What is Known:
• Long-term outcomes of patients with KD and CAA are primarily driven by the consequences of CAA regression and progression.
• Regression and progression occurs more frequently in patients with small- and medium-sized CAAs, and less frequently for giant CAAs.
What is New:
• The CAA size at diagnosis, NCAI, and the proportion of lymphocytes are presumably associated with the small- and medium-sized CAA persistence or CAA progression.
• The CAA progression was associated with CAA persistence.
Literature
1.
go back to reference Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F (2003) Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide Biol Chem 8:15–25CrossRef Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F (2003) Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide Biol Chem 8:15–25CrossRef
2.
go back to reference Advani N, Sastroasmoro S, Ontoseno T, Uiterwaal CS (2018) Long-term outcome of coronary artery dilatation in Kawasaki disease. Annals of pediatric cardiology 11:125–129CrossRef Advani N, Sastroasmoro S, Ontoseno T, Uiterwaal CS (2018) Long-term outcome of coronary artery dilatation in Kawasaki disease. Annals of pediatric cardiology 11:125–129CrossRef
3.
go back to reference Chen PT, Lin MT, Chen YS, Chen SJ, Wu MH (2017) Computed tomography predict regression of coronary artery aneurysm in patients with Kawasaki disease, Journal of the Formosan Medical Association = Taiwan yi zhi. 116:806–814 Chen PT, Lin MT, Chen YS, Chen SJ, Wu MH (2017) Computed tomography predict regression of coronary artery aneurysm in patients with Kawasaki disease, Journal of the Formosan Medical Association = Taiwan yi zhi. 116:806–814
4.
go back to reference Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH (2016) Progressive coronary dilatation predicts worse outcome in Kawasaki disease. J Pediatr 171:78–82 e71CrossRef Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH (2016) Progressive coronary dilatation predicts worse outcome in Kawasaki disease. J Pediatr 171:78–82 e71CrossRef
5.
go back to reference Dietz SM, Kuipers IM, Koole JCD, Breur J, Fejzic Z, Frerich S, Dalinghaus M, Roest AAW, Hutten BA, Kuijpers TW (2017) Regression and complications of z-score-based giant aneurysms in a Dutch cohort of Kawasaki disease patients. Pediatr Cardiol 38:833–839CrossRef Dietz SM, Kuipers IM, Koole JCD, Breur J, Fejzic Z, Frerich S, Dalinghaus M, Roest AAW, Hutten BA, Kuijpers TW (2017) Regression and complications of z-score-based giant aneurysms in a Dutch cohort of Kawasaki disease patients. Pediatr Cardiol 38:833–839CrossRef
6.
go back to reference Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5 Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5
7.
go back to reference Fujii M, Tanaka H, Nakamura A, Suzuki C, Harada Y, Takamatsu T, Hamaoka K (2016) Histopathological characteristics of post-inflamed coronary arteries in Kawasaki disease-like vasculitis of rabbits. Acta Histochem Cytochem 49:29–36CrossRef Fujii M, Tanaka H, Nakamura A, Suzuki C, Harada Y, Takamatsu T, Hamaoka K (2016) Histopathological characteristics of post-inflamed coronary arteries in Kawasaki disease-like vasculitis of rabbits. Acta Histochem Cytochem 49:29–36CrossRef
8.
go back to reference Fukushige J, Takahashi N, Ueda K, Hijii T, Igarashi H, Ohshima A (1996) Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 17:71–76CrossRef Fukushige J, Takahashi N, Ueda K, Hijii T, Igarashi H, Ohshima A (1996) Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 17:71–76CrossRef
9.
go back to reference Han CL, Zhao SL (2018) Intravenous immunoglobulin gamma (IVIG) versus IVIG plus infliximab in young children with Kawasaki disease. Medical science monitor : international medical journal of experimental and clinical research 24:7264–7270CrossRef Han CL, Zhao SL (2018) Intravenous immunoglobulin gamma (IVIG) versus IVIG plus infliximab in young children with Kawasaki disease. Medical science monitor : international medical journal of experimental and clinical research 24:7264–7270CrossRef
10.
go back to reference JCS Joint Working Group (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Circ J 78:2521–2562 JCS Joint Working Group (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Circ J 78:2521–2562
11.
go back to reference Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. CIR 94:1379–1385 Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. CIR 94:1379–1385
12.
go back to reference Liu MY, Liu HM, Wu CH, Chang CH, Huang GJ, Chen CA, Chiu SN, Lu CW, Lin MT, Chang LY, Wang JK, Wu MH (2017) Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease. BMC Pediatr 17:139CrossRef Liu MY, Liu HM, Wu CH, Chang CH, Huang GJ, Chen CA, Chiu SN, Lu CW, Lin MT, Chang LY, Wang JK, Wu MH (2017) Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease. BMC Pediatr 17:139CrossRef
13.
go back to reference Manlhiot C, Niedra E, McCrindle BW (2013) Long-term management of Kawasaki disease: implications for the adult patient. Pediatrics and neonatology 54:12–21CrossRef Manlhiot C, Niedra E, McCrindle BW (2013) Long-term management of Kawasaki disease: implications for the adult patient. Pediatrics and neonatology 54:12–21CrossRef
14.
go back to reference McNeal-Davidson A, Fournier A, Scuccimarri R, Dancea A, Houde C, Bellavance M, Dahdah N (2013) The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the province of Quebec: the complete series since 1976. Pediatr Cardiol 34:170–178CrossRef McNeal-Davidson A, Fournier A, Scuccimarri R, Dancea A, Houde C, Bellavance M, Dahdah N (2013) The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the province of Quebec: the complete series since 1976. Pediatr Cardiol 34:170–178CrossRef
15.
go back to reference Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111:38–43CrossRef Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111:38–43CrossRef
16.
go back to reference Mueller F, Knirsch W, Harpes P, Pretre R, Valsangiacomo Buechel E, Kretschmar O (2009) Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions. Clinical research in cardiology : official journal of the German Cardiac Society 98:501–507CrossRef Mueller F, Knirsch W, Harpes P, Pretre R, Valsangiacomo Buechel E, Kretschmar O (2009) Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions. Clinical research in cardiology : official journal of the German Cardiac Society 98:501–507CrossRef
17.
go back to reference Murphy DJ Jr, Huhta JC (1987) Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 316:881CrossRef Murphy DJ Jr, Huhta JC (1987) Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 316:881CrossRef
18.
go back to reference Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, Jain S, Silverstein L, Baker AL, Tanaka N, Ogihara Y, Ikehara S, Takatsuki S, Sakamoto N, Kobayashi T, Fuse S, Matsubara T, Ishii M, Saji T, Newburger JW, Burns JC (2013) Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol 168:3825–3828CrossRef Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, Jain S, Silverstein L, Baker AL, Tanaka N, Ogihara Y, Ikehara S, Takatsuki S, Sakamoto N, Kobayashi T, Fuse S, Matsubara T, Ishii M, Saji T, Newburger JW, Burns JC (2013) Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol 168:3825–3828CrossRef
19.
go back to reference Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarevian JP, Perlman EJ, Trevenen C, Rotta AT, Kalelkar MB, Rowley AH (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7:e38998CrossRef Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarevian JP, Perlman EJ, Trevenen C, Rotta AT, Kalelkar MB, Rowley AH (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7:e38998CrossRef
20.
go back to reference Ronai C, Hamaoka-Okamoto A, Baker AL, de Ferranti SD, Colan SD, Newburger JW, Friedman KG (2016) Coronary artery aneurysm measurement and Z score variability in Kawasaki disease. J Am Soc Echocardiogr 29:150–157CrossRef Ronai C, Hamaoka-Okamoto A, Baker AL, de Ferranti SD, Colan SD, Newburger JW, Friedman KG (2016) Coronary artery aneurysm measurement and Z score variability in Kawasaki disease. J Am Soc Echocardiogr 29:150–157CrossRef
21.
go back to reference Samada K, Shiraishi H, Sato A, Momoi MY (2010) Grown-up Kawasaki disease patients who have giant coronary aneurysms. World journal of pediatrics : WJP 6:38–42CrossRef Samada K, Shiraishi H, Sato A, Momoi MY (2010) Grown-up Kawasaki disease patients who have giant coronary aneurysms. World journal of pediatrics : WJP 6:38–42CrossRef
22.
go back to reference Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. CIR 75:387–394CrossRef Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. CIR 75:387–394CrossRef
23.
go back to reference Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H (2018) Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China. Clin Rheumatol 37:1945–1951CrossRef Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H (2018) Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China. Clin Rheumatol 37:1945–1951CrossRef
24.
go back to reference Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H, Yoshibayashi M (2014) A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J 167:249–258CrossRef Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H, Yoshibayashi M (2014) A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J 167:249–258CrossRef
25.
go back to reference Tsuda E, Tsujii N, Hayama Y (2017) Cardiac events and the maximum diameter of coronary artery aneurysms in Kawasaki disease. J Pediatr 188:70–74.e71CrossRef Tsuda E, Tsujii N, Hayama Y (2017) Cardiac events and the maximum diameter of coronary artery aneurysms in Kawasaki disease. J Pediatr 188:70–74.e71CrossRef
Metadata
Title
Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study
Authors
Lei Liu
Chunyan Luo
Yimin Hua
Mei Wu
Shuran Shao
Xiaoliang Liu
Kaiyu Zhou
Chuan Wang
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 6/2020
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-019-03492-8

Other articles of this Issue 6/2020

European Journal of Pediatrics 6/2020 Go to the issue